CC BY-NC-ND 4.0 · Ibnosina Journal of Medicine and Biomedical Sciences 2022; 14(02): 045
DOI: 10.1055/s-0042-1756683
Editorial

Cancer Survivorship, Diabetes, and Pain Control

1   Division of Transplantation, Department of Surgery, The Ohio State University, Columbus, Ohio, United States
,
2   Department of Medicine, Dubai Medical College for Girls, Dubai, United Arab Emirates
3   Department of Endocrinology, Yas Clinic Khalifa City, Abu Dhabi, United Arab Emirates
4   Department of Medicine, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, United Arab Emirates
› Author Affiliations
Funding and Sponsorship None.

The current issue is small. However, we have a variety of contributions that we hope will meet the expectations of our authors. Singarachari wrote a thought-provoking viewpoint on the status of cancer survivorship care in general and how it should improve! Also, Hassan-Beck et al from the Diabetes and Ramadan Group revisited the global literature production on the subject excluding diabetes during the last year. The sports medicine, cardiovascular and maternal health seemed to attract lots of interest. The impact on physiology and nutrition seem to be a continuing focus.

Two original articles are included in the issue. First, Bedel et al contributed a prospective randomized controlled trial on the vapocoolant spray for pain control in intramuscular injection applications. Second, Elbanoni et al compared the use of STRONGkids and anthropometry for the assessment of the nutritional status of hospitalized children in Benghazi.

Case report and focused review of the literature discussed a possible case of Flatbush diabetes with severe hypertriglyceridemia that was presented by Al-Nuaimi et al and finally, letter to the editor, from Rissardo and Caprara, elaborated on some interesting aspects of the neurological complications associated with hemodialysis.

We hope that our readers benefit and enjoy these contributions.

Authors' Contributions

Equal.


Compliance with Ethical Principles

No ethical approval is required.




Publication History

Article published online:
13 October 2022

© 2022. The Libyan Authority of Scientific Research and Technology and the Libyan Biotechnology Research Center. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India